Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Moore

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
Journal of Protein Chemistry|June 1, 1991
Proton NMR studies of angiotensin II and its analogs in aqueous solutionN Zhou, G J Moore, H J Vogel
Endocrinology|October 1, 1981
Putative precursors of vasopressin, oxytocin, and neurophysins in the rat hypothalamusJ C Rosenior, W G North, G J Moore
Biochimica Et Biophysica Acta|May 31, 1991
Fluorescence properties of angiotensin II analogues in receptor-simulating environments: relationship between tyrosinate fluorescence lifetime and biological activityR J Turner, J M Matsoukas, G J Moore
International Journal of Peptide and Protein Research|November 1, 1993
Influence of methylation of the histidine ring of [Sar1]angiotensin II on conformation and biological activityG J Moore, M H Goghari, K J Franklin
American Journal of Veterinary Research|June 1, 1970
Protective efficacy of live- and dead-virus rabies vaccines in offspring (mice) of immune damsJ F Bell, G J Moore, G H Raymond
Journal of Medicinal Chemistry|June 1, 1986
Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin)M H Goghari, K J Franklin, G J Moore
Biochemical and Biophysical Research Communications|May 15, 1989
Angiotensin 'antipeptides': (-)messenger RNA complementary to human angiotensin II (+)messenger RNA encodes an angiotensin receptor antagonistG J Moore, R C Ganter, K J Franklin
Proceedings of the Western Pharmacology Society|January 1, 1985
Structure dependence of angiotensin tachyphylaxis and the mechanisms of saralasin like and sarmesin like antagonismG J Moore, K J Franklin, D M Nystrom
Proceedings of the Western Pharmacology Society|March 4, 2000
Design of mimetics of gonadotropin releasing hormone (GnRH) with effects on proliferation of breast cancer cellsG J Moore, J M Pires, L J Hayden
Biochemical and Biophysical Research Communications|September 28, 1990
Tyrosinate fluorescence lifetimes for oxytocin and vasopressin in receptor-simulating environments: relationship to biological activity and 1H-NMR dataR J Turner, J M Matsoukas, G J Moore
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Journal of Protein Chemistry|June 1, 1991
Proton NMR studies of angiotensin II and its analogs in aqueous solutionN Zhou, G J Moore, H J Vogel
Endocrinology|October 1, 1981
Putative precursors of vasopressin, oxytocin, and neurophysins in the rat hypothalamusJ C Rosenior, W G North, G J Moore
Biochimica Et Biophysica Acta|May 31, 1991
Fluorescence properties of angiotensin II analogues in receptor-simulating environments: relationship between tyrosinate fluorescence lifetime and biological activityR J Turner, J M Matsoukas, G J Moore
International Journal of Peptide and Protein Research|November 1, 1993
Influence of methylation of the histidine ring of [Sar1]angiotensin II on conformation and biological activityG J Moore, M H Goghari, K J Franklin
American Journal of Veterinary Research|June 1, 1970
Protective efficacy of live- and dead-virus rabies vaccines in offspring (mice) of immune damsJ F Bell, G J Moore, G H Raymond
Journal of Medicinal Chemistry|June 1, 1986
Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin)M H Goghari, K J Franklin, G J Moore
Biochemical and Biophysical Research Communications|May 15, 1989
Angiotensin 'antipeptides': (-)messenger RNA complementary to human angiotensin II (+)messenger RNA encodes an angiotensin receptor antagonistG J Moore, R C Ganter, K J Franklin
Proceedings of the Western Pharmacology Society|January 1, 1985
Structure dependence of angiotensin tachyphylaxis and the mechanisms of saralasin like and sarmesin like antagonismG J Moore, K J Franklin, D M Nystrom
Proceedings of the Western Pharmacology Society|March 4, 2000
Design of mimetics of gonadotropin releasing hormone (GnRH) with effects on proliferation of breast cancer cellsG J Moore, J M Pires, L J Hayden
Biochemical and Biophysical Research Communications|September 28, 1990
Tyrosinate fluorescence lifetimes for oxytocin and vasopressin in receptor-simulating environments: relationship to biological activity and 1H-NMR dataR J Turner, J M Matsoukas, G J Moore
Pageof 17